Riskpilot← Back to searchSign inGet full accessBIOMEDIQ A/S
A/SActiveCVR 31176891Danneskiold-Samsøes Allé 41, st.Research and experimental development on natural sciences and engineering · NACE 7210Est. 20081 employees
Revenue 2024
DKK -75K
+48% vs 2023
EBITDA margin
77.8%
-15% vs 2023
Equity ratio
-6.0%
Financial strength
Net profit 2024
DKK -57K
+3% vs 2023
| Revenue | DKK -75K | +48% |
| EBITDA | DKK -58K | -15% |
| Net profit | DKK -57K | +3% |
| Total assets | DKK 40K | -66% |
| Equity | DKK -2K | -104% |
| Employees | 1 | — |
Legal name
BIOMEDIQ A/S
CVR number
31176891
Legal form
Aktieselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
1. januar 2008
Share capital
DKK 400.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af formanden for bestyrelsen eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at drive virksomhed indenfor bioteknologi og anden dermed i forbindelse stående virksomhed.
Address
Danneskiold-Samsøes Allé 41, st.
Phone
+4524600599
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1.023 | 548 | 12 | -51 | -75 |
| Staff expenses | -944 | -218 | -27 | -0 | -17 |
| EBITDA | 79 | 330 | -15 | -51 | -58 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | 79 | 330 | -15 | -51 | -58 |
| Net financials | -13 | -14 | -9 | -8 | -7 |
| Profit before tax | 66 | 316 | -24 | -58 | -65 |
| Tax | 15 | 69 | 296 | -0 | -9 |
| Net profit | 51 | 247 | -320 | -58 | -57 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1.488 | 1.086 | 226 | 119 | 40 |
| Equity | 1.161 | 933 | 113 | 54 | -2 |
| Long-term debt | 97 | 61 | 61 | 17 | 0 |
| Short-term debt | 229 | 92 | 53 | 47 | 42 |
| Total debt | 327 | 153 | 113 | 64 | 42 |
EBITDA margin
-5834500.0%
This company
15.8%
Market median
-36927315% vs market
20202024
Equity ratio
-6.0%
This company
38.2%
Market median
-116% vs market
20202024
Return on equity
-5666900.0%
This company
18.4%
Market median
-30798470% vs market
20202024
Net profit margin
-5666900.0%
This company
8.1%
Market median
-69961828% vs market
20202024
Asset turnover
-1.89×
This company
1.12×
Market median
-269% vs market
20202024
Debt / equity
17.57×
This company
0.62×
Market median
-2734% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MN Management | Management | 2011 |
| Former (3) | ||
TN Management | Management | 2008 – 2009 |
SH Management | Management | 2009 – 2011 |
CH Management | Management | 2008 – 2008 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2025 | |
| Board of Directors | 2011 | |
| Former (4) | ||
| Chairman | 2008 – 2011 | |
| Board of Directors | 2011 – 2025 | |
| Board of Directors | 2008 – 2011 | |
| Board of Directors | 2008 – 2008 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 2025 | |
| Company | 20–24.99% | 20–24.99% | 2011 | |
| Company | 50–66.65% | 50–66.65% | 2022 | |
| Company | 20–24.99% | 20–24.99% | 2011 | |
| Company | 50–66.65% | 50–66.65% | 2020 | |
| Company | 20–24.99% | 20–24.99% | 2014 | |
| Company | 33.33–49.99% | 33.33–49.99% | 2011 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BIOMEDIQ A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Thomas Nielsen | Management | 0 companies |
| Mads Nielsen | Management | 0 companies |
| Søren Hyllekvist | Management | 0 companies |
| Claus Henrik Christiansen | Management | 0 companies |
| Aaron Christopher Timm | Chairman | 0 companies |
| Erik Bjørnager Dam | Board of Directors | 0 companies |
| Ralph J. Reyes | Board of Directors | 0 companies |
| Pieter Kroese | Chairman | 0 companies |
| Martin Lillholm | Board of Directors | 0 companies |
| Morten Asser Karsdal | Board of Directors | 0 companies |